BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 1645617)

  • 21. Simultaneous cytokinetic measurement of aneuploid tumors and associated diploid cells following continuous labelling with chlorodeoxyuridine.
    White RA; Pollack A; Terry NH
    Cytometry; 1994 Apr; 15(4):311-9. PubMed ID: 8026221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.
    Dressler LG; Seamer L; Owens MA; Clark GM; McGuire WL
    Cancer Res; 1987 Oct; 47(20):5294-302. PubMed ID: 3652035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FISH cytogenetics and prognosis in breast and non-small cell lung cancers.
    Massoner A; Augustin F; Duba HC; Zojer N; Fiegl M
    Cytometry B Clin Cytom; 2004 Nov; 62(1):52-6. PubMed ID: 15468329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
    Teodori L; Tirindelli-Danesi D; Mauro F; De Vita R; Uccelli R; Botti C; Modini C; Nervi C; Stipa S
    Cytometry; 1983 Sep; 4(2):174-83. PubMed ID: 6313307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
    Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
    Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of features of human lung cancer cell lines and their corresponding tumors.
    Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
    Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic diversity in primary human tumors.
    Wolman SR; Camuto PM; Perle MA
    J Cell Biochem; 1988 Feb; 36(2):147-56. PubMed ID: 3281959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis of primary lung carcinomas and their lymph node metastases.
    Volm M; Mattern J; Vogt-Schaden M; Wayss K
    Anticancer Res; 1987; 7(1):71-6. PubMed ID: 3032072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.
    Choma D; Daurès JP; Quantin X; Pujol JL
    Br J Cancer; 2001 Jul; 85(1):14-22. PubMed ID: 11437396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Flow cytometric analysis of nuclear DNA content of lung cancer--correlation between nuclear DNA content and tumor doubling time].
    Usuda K; Saito Y; Aikawa H; Sakurada A; Chen Y; Takahashi S; Kanma K; Sato M; Sagawa M; Fujimura S
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):486-91. PubMed ID: 8035066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Centrosome abnormalities in non-small cell lung cancer: correlations with DNA aneuploidy and expression of cell cycle regulatory proteins.
    Jung CK; Jung JH; Lee KY; Kang CS; Kim M; Ko YH; Oh CS
    Pathol Res Pract; 2007; 203(12):839-47. PubMed ID: 17913384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
    Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
    Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
    Virmani AK; Tonk VS; Gazdar AF
    Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of DNA ploidy in archival tissue from non-Hodgkin's lymphoma using flow and image cytometry.
    Zbieranowski I; Le Riche JC; Palcic B; Gascoyne R; Connors J
    Anal Cell Pathol; 1992 Jul; 4(4):303-13. PubMed ID: 1390299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology.
    Ołszewski W; Darzynkiewicz Z; Claps ML; Melamed MR
    Anal Quant Cytol; 1982 Jun; 4(2):90-8. PubMed ID: 6287892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.
    Frankfurt OS; Slocum HK; Rustum YM; Arbuck SG; Pavelic ZP; Petrelli N; Huben RP; Pontes EJ; Greco WR
    Cytometry; 1984 Jan; 5(1):71-80. PubMed ID: 6199167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.